These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 34764115

  • 21. Current Concepts in the Treatment of Giant Cell Tumor of Bone: An Update.
    Tsukamoto S, Mavrogenis AF, Masunaga T, Honoki K, Fujii H, Kido A, Tanaka Y, Errani C.
    Curr Oncol; 2024 Apr 08; 31(4):2112-2132. PubMed ID: 38668060
    [Abstract] [Full Text] [Related]

  • 22. Combined preoperative denosumab and adjuvant microwave ablation for high-risk giant cell tumor of bone: a retrospective study in a single center.
    Zheng C, Xu G, Zhou X, Qiu J, Lan T, Zhang S, Li W.
    J Orthop Surg Res; 2024 Aug 17; 19(1):488. PubMed ID: 39154187
    [Abstract] [Full Text] [Related]

  • 23. Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone.
    Puri A, Gulia A, Hegde P, Verma V, Rekhi B.
    Bone Joint J; 2019 Feb 17; 101-B(2):170-177. PubMed ID: 30700112
    [Abstract] [Full Text] [Related]

  • 24. Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.
    Sano K, Suehara Y, Okubo T, Sasa K, Kurihara T, Akaike K, Kubota D, Torigoe T, Hasegawa N, Ishii M, Nakamura Y, Kim Y, Takagi T, Kaneko K, Hayashi T, Saito T.
    J Orthop Surg (Hong Kong); 2020 Feb 17; 28(2):2309499020929786. PubMed ID: 32539628
    [Abstract] [Full Text] [Related]

  • 25. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
    Medellin MR, Fujiwara T, Tillman RM, Jeys LM, Gregory J, Stevenson JD, Parry M, Abudu A.
    Bone Joint J; 2018 Dec 17; 100-B(12):1626-1632. PubMed ID: 30499317
    [Abstract] [Full Text] [Related]

  • 26. Denosumab does not decrease the risk of lung metastases from bone giant cell tumour.
    Tsukamoto S, Mavrogenis AF, Leone G, Righi A, Akahane M, Tanzi P, Kido A, Honoki K, Tanaka Y, Donati DM, Errani C.
    Int Orthop; 2019 Feb 17; 43(2):483-489. PubMed ID: 30099641
    [Abstract] [Full Text] [Related]

  • 27. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.
    Tsukamoto S, Tanaka Y, Mavrogenis AF, Kido A, Kawaguchi M, Errani C.
    Clin Orthop Relat Res; 2020 May 17; 478(5):1076-1085. PubMed ID: 31794487
    [Abstract] [Full Text] [Related]

  • 28. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
    Takeuchi A, Tsuchiya H, Ishii T, Nishida Y, Abe S, Matsumine A, Kawai A, Yoshimura K, Ueda T.
    BMC Musculoskelet Disord; 2016 Jul 22; 17():306. PubMed ID: 27448567
    [Abstract] [Full Text] [Related]

  • 29. Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage.
    Errani C, Tsukamoto S, Leone G, Righi A, Akahane M, Tanaka Y, Donati DM.
    J Bone Joint Surg Am; 2018 Mar 21; 100(6):496-504. PubMed ID: 29557866
    [Abstract] [Full Text] [Related]

  • 30. Denosumab for an inoperable giant cell tumour of the ischial bone.
    Paul AG, See LP, Ohn MH, Ohn KM.
    BMJ Case Rep; 2023 Dec 18; 16(12):. PubMed ID: 38110341
    [Abstract] [Full Text] [Related]

  • 31. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery.
    von Borstel D, A Taguibao R, A Strle N, E Burns J.
    Skeletal Radiol; 2017 Apr 18; 46(4):571-578. PubMed ID: 28188337
    [Abstract] [Full Text] [Related]

  • 32. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
    Agarwal MG, Gundavda MK, Gupta R, Reddy R.
    Clin Orthop Relat Res; 2018 Sep 18; 476(9):1773-1782. PubMed ID: 30794215
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of Giant Cell Tumor of Bone in the Distal Radius and Ulna].
    Mahdal M, Jindra J, Staniczková Zambo I, Pazourek L, Nachtnebl L, Tomáš T.
    Acta Chir Orthop Traumatol Cech; 2022 Sep 18; 89(3):188-192. PubMed ID: 35815484
    [Abstract] [Full Text] [Related]

  • 34. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
    Rutkowski P, Gaston L, Borkowska A, Stacchiotti S, Gelderblom H, Baldi GG, Palmerini E, Casali P, Gronchi A, Parry M, Campanacci DA, Scoccianti G, Wagrodzki M, Ferrari S, Dijkstra S, Pieńkowski A, Grimer R.
    Eur J Surg Oncol; 2018 Sep 18; 44(9):1384-1390. PubMed ID: 29650420
    [Abstract] [Full Text] [Related]

  • 35. Giant Cell Tumor of Bone of the First Rib Successfully Treated with Combined Preoperative Denosumab Therapy and Surgery via a Transmanubrial Approach.
    Matsunobu T, Maekawa A, Nabeshima A, Sakamoto A, Tamura K, Odate S, Iwamoto Y.
    Am J Case Rep; 2021 Jun 01; 22():e931796. PubMed ID: 34059614
    [Abstract] [Full Text] [Related]

  • 36. Current management of giant-cell tumor of bone in the denosumab era.
    Nagano A, Urakawa H, Tanaka K, Ozaki T.
    Jpn J Clin Oncol; 2022 May 05; 52(5):411-416. PubMed ID: 35199172
    [Abstract] [Full Text] [Related]

  • 37. Role of denosumab before resection and reconstruction in giant cell tumors of bone: a single-centered retrospective cohort study.
    Sahito B, Ali SME, Kumar D, Kumar J, Hussain N, Lakho T.
    Eur J Orthop Surg Traumatol; 2022 Apr 05; 32(3):567-574. PubMed ID: 34050817
    [Abstract] [Full Text] [Related]

  • 38. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
    Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H.
    Eur Spine J; 2017 May 05; 26(Suppl 1):236-242. PubMed ID: 28396950
    [Abstract] [Full Text] [Related]

  • 39. Denosumab for Bone Giant Cell Tumor of the Distal Radius.
    Tsukamoto S, Mavrogenis AF, Tanzi P, Leone G, Ciani G, Righi A, Akahane M, Honoki K, Tanaka Y, Donati DM, Errani C.
    Orthopedics; 2020 Sep 01; 43(5):284-291. PubMed ID: 32745221
    [Abstract] [Full Text] [Related]

  • 40. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
    Chawla S, Blay JY, Rutkowski P, Le Cesne A, Reichardt P, Gelderblom H, Grimer RJ, Choy E, Skubitz K, Seeger L, Schuetze SM, Henshaw R, Dai T, Jandial D, Palmerini E.
    Lancet Oncol; 2019 Dec 01; 20(12):1719-1729. PubMed ID: 31704134
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.